12/14/2011 Nu Skin Enterprises Acquires LifeGen Technologies
Press Release
10/21/2010 - LifeGen Technologies awarded Phase I SBIR grant from the National Institute on Aging
More information here
10/22/2009 - Nu Skin signs Research Agreement with LifeGen Technologies
LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie
restriction
1/25/2009 Link
to story and video
LifeGen researchers report that consumption of a low dose of the red wine molecule resveratrol mimics the gene
expression profile of mice subjected to a calorie-restricted diet.
6/4/2008 - PLoS
ONE
Howard V. Raff Ph.D.
Director
Dr. Howard V. Raff is the Chief Operating Officer at APT Pharmaceuticals, a drug development company focused on repurposing well-characterized drugs for under-served populations. Howie previously served as the Head of West Coast Operations for The Biologics Consulting Group and held executive positions for Chiron Corporation. He also spent 11 years in discovery research and development for Bristol-Myers Squibb. Howie has been involved with the development and approval of several drugs in the U.S. and Europe, including: CTLA4-lg, Proleukin, Menjugate vaccine and Cubicin. He earned a Ph.D in immunology from Washington State University and earned a fellowship from the Howard Hughes Medical Institute at the University of California – San Francisco.